Stuart Arbuckle
Chief Operating Officer at VERTEX PHARMACEUTICALS INCORPORATED
Net worth: 21 M $ as of 2024-03-30
Profile
Mr. Stuart A. Arbuckle is an Independent Director at Rhythm Pharmaceuticals, Inc., an Independent Director at ImmunoGen, Inc. and a Chief Operating Officer & Executive Vice President at Vertex Pharmaceuticals, Inc. He is on the Board of Directors at Rhythm Pharmaceuticals, Inc., ImmunoGen, Inc., Biotechnology Innovation Organization and Cancer Support Community. Mr. Arbuckle was previously employed as a Vice President & GM-Oncology Business Unit by Amgen, Inc. and a Principal by GlaxoSmithKline Plc. He also served on the board at Cerulean Pharma, Inc. and Wellness Community. He received his undergraduate degree from the University of Leeds.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2024-02-25 | 49,831 ( 0.02% ) | 21 M $ | 2024-03-30 |
Stuart Arbuckle active positions
| Companies | Position | Start |
|---|---|---|
| VERTEX PHARMACEUTICALS INCORPORATED | Chief Operating Officer | 2021-01-31 |
| RHYTHM PHARMACEUTICALS, INC. | Director/Board Member | 2019-07-23 |
Cancer Support Community
 Cancer Support Community Miscellaneous Commercial ServicesCommercial Services Cancer Support Community is an American company that provides support to people with cancer. The non-profit company is based in Washington. The company focuses on helping those who experience cancer cachexia, a syndrome that causes drastic weight and muscle loss in cancer patients. The company was founded in 1982 by Harold Benjamin. Debbie Weir has been the CEO of the company since 2022. | Director/Board Member | - |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Director/Board Member | - |
Former positions of Stuart Arbuckle
| Companies | Position | End |
|---|---|---|
| IMMUNOGEN, INC. | Director/Board Member | 2024-02-11 |
Cerulean Pharma, Inc.
 Cerulean Pharma, Inc. Pharmaceuticals: MajorHealth Technology Cerulean Pharma, Inc. is a clinical-stage, oncology-focused company, which provides proprietary Dynamic Tumor Targeting Platform to develop differentiated therapies. It specializes in the design and development of nanopharmaceuticals. Cerulean's nanopharmaceuticals are drug-containing nanoparticles designed and optimized to enhance therapeutic agents, ranging from small molecules to therapeutic peptides and RNAi molecules. The company was founded by Alan L. Crane and Ram Sasisekharn on November 28, 2005 and is headquartered in Waltham, MA. | Director/Board Member | 2017-06-30 |
| AMGEN INC. | Corporate Officer/Principal | 2012-07-31 |
| GSK PLC | Corporate Officer/Principal | - |
Wellness Community
 Wellness Community Miscellaneous Commercial ServicesCommercial Services Wellness Community was an outlet for those suffering cancer to receive appropriate support. The company was founded in 1982 and was headquartered in Washington, DC. | Director/Board Member | - |
Training of Stuart Arbuckle
| University of Leeds | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 5 |
|---|---|
| AMGEN INC. | Health Technology |
| IMMUNOGEN, INC. | Health Technology |
| VERTEX PHARMACEUTICALS INCORPORATED | Health Technology |
| RHYTHM PHARMACEUTICALS, INC. | Health Technology |
| GSK PLC | Health Technology |
| Private companies | 4 |
|---|---|
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Commercial Services |
Wellness Community
Wellness Community Miscellaneous Commercial ServicesCommercial Services Wellness Community was an outlet for those suffering cancer to receive appropriate support. The company was founded in 1982 and was headquartered in Washington, DC. | Commercial Services |
Cerulean Pharma, Inc.
Cerulean Pharma, Inc. Pharmaceuticals: MajorHealth Technology Cerulean Pharma, Inc. is a clinical-stage, oncology-focused company, which provides proprietary Dynamic Tumor Targeting Platform to develop differentiated therapies. It specializes in the design and development of nanopharmaceuticals. Cerulean's nanopharmaceuticals are drug-containing nanoparticles designed and optimized to enhance therapeutic agents, ranging from small molecules to therapeutic peptides and RNAi molecules. The company was founded by Alan L. Crane and Ram Sasisekharn on November 28, 2005 and is headquartered in Waltham, MA. | Health Technology |
Cancer Support Community
Cancer Support Community Miscellaneous Commercial ServicesCommercial Services Cancer Support Community is an American company that provides support to people with cancer. The non-profit company is based in Washington. The company focuses on helping those who experience cancer cachexia, a syndrome that causes drastic weight and muscle loss in cancer patients. The company was founded in 1982 by Harold Benjamin. Debbie Weir has been the CEO of the company since 2022. | Commercial Services |
- Stock Market
- Insiders
- Stuart Arbuckle
